Shikimic acid promotes estrogen receptor(ER)-positive breast cancer cells proliferation via activation of NF-κB signaling.
暂无分享,去创建一个
[1] Fasoulakis N. Zacharias,et al. The Impact of microRNAs in Breast Cancer Angiogenesis and Progression. , 2019, MicroRNA.
[2] Angeles C. Tecalco-Cruz,et al. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells. , 2019, Current drug targets.
[3] K. Saliminejad,et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods , 2018, Journal of cellular physiology.
[4] L. Szulc-Dąbrowska,et al. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives , 2018, Cancers.
[5] M. Srinivasan,et al. Mechanisms of NF-κB p65 and strategies for therapeutic manipulation , 2018, Journal of inflammation research.
[6] Liangliang Wang,et al. Shikimic acid prevents cartilage matrix destruction in human chondrocytes , 2018, International immunopharmacology.
[7] Xuqi Li,et al. Upregulation of microRNA‑300 induces the proliferation of liver cancer by downregulating transcription factor FOXO1. , 2018, Oncology reports.
[8] Chi-Tang Ho,et al. Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy , 2018, Molecular nutrition & food research.
[9] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[10] Xiaohe Yang,et al. microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy , 2018, Biological Procedures Online.
[11] Yan Sun,et al. MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition , 2018, OncoTargets and therapy.
[12] G. Jiang,et al. Polyfluorinated iodine alkanes regulated distinct breast cancer cell progression through binding with estrogen receptor alpha or beta isoforms. , 2018, Environmental pollution.
[13] A. Brown. Cancer Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 5 of 5 , 2018, Journal of dietary supplements.
[14] H. Koch,et al. Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines , 2018, Toxicological sciences : an official journal of the Society of Toxicology.
[15] Ali Akbar Haghdoost,et al. Candidate miRNAs in human breast cancer biomarkers: a systematic review , 2018, Breast Cancer.
[16] M. Naumann,et al. NEMO Links Nuclear Factor-κB to Human Diseases. , 2017, Trends in molecular medicine.
[17] Yeon-Hee Park. The nuclear factor-kappa B pathway and response to treatment in breast cancer. , 2017, Pharmacogenomics.
[18] Mark Merchant,et al. Crocodylian nuclear factor kappa B. , 2017, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[19] C. M. Lopes,et al. Phytotherapy and Nutritional Supplements on Breast Cancer , 2017, BioMed research international.
[20] C. Petraki,et al. The COOH-terminus of the IGF-1Ec Isoform Enhances the Proliferation and Migration of Human MCF-7 Breast Cancer Cells. , 2017, Anticancer research.
[21] Dan Liu,et al. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1 , 2017, Clinical and Translational Oncology.
[22] Longyang Jin,et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] Jinxiu Sheng,et al. Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma. , 2017, European review for medical and pharmacological sciences.
[24] Hong Dai,et al. Increased serum miR-300 level serves as a potential biomarker of lipopolysaccharide-induced lung injury by targeting IκBα. , 2017, Die Pharmazie.
[25] C. Panuzzo,et al. IκB-α: At the crossroad between oncogenic and tumor-suppressive signals , 2016, Oncology letters.
[26] R. B. Ruiz,et al. Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence. , 2016 .
[27] A. Bishayee,et al. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. , 2016, Seminars in cancer biology.
[28] R. Green,et al. Connections Underlying Translation and mRNA Stability. , 2016, Journal of molecular biology.
[29] A. Santhakumar,et al. Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population. , 2016, Food & function.
[30] M. Nobre,et al. Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer , 2016, Journal of oncology.
[31] Chih-Hsin Tang,et al. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells , 2016, Oncotarget.
[32] Hong Gao,et al. Antibacterial Activity of Shikimic Acid from Pine Needles of Cedrus deodara against Staphylococcus aureus through Damage to Cell Membrane , 2015, International journal of molecular sciences.
[33] Da-Wei Li,et al. MiR-300 regulate the malignancy of breast cancer by targeting p53. , 2015, International journal of clinical and experimental medicine.
[34] D. Gelain,et al. In Vitro Neuroprotective Effect of Shikimic Acid Against Hydrogen Peroxide-Induced Oxidative Stress , 2015, Journal of Molecular Neuroscience.
[35] F. Cardoso,et al. Breast Cancer Under Age 40: a Different Approach , 2015, Current Treatment Options in Oncology.
[36] Christoph Engel,et al. Breast Cancer Risks and Risk Prediction Models , 2015, Breast Care.
[37] H. Mahboobi,et al. Lifestyle changes for prevention of breast cancer , 2014, Electronic physician.
[38] Qin Xu,et al. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer , 2014, Molecular Cancer.
[39] D. Marchioni,et al. Breast cancer and dietary patterns: a systematic review. , 2014, Nutrition reviews.
[40] Yu Zhou,et al. Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBα , 2012, PloS one.
[41] M. Aapro,et al. Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: a review of the literature. , 2012, Breast.
[42] Amalia Estévez,et al. A short overview on the medicinal chemistry of (-)-shikimic acid. , 2012, Mini reviews in medicinal chemistry.
[43] Jun Li,et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. , 2012, The Journal of clinical investigation.
[44] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[45] Y. Ju,et al. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[46] J. Ashby,et al. The mutagenic and cell transforming properties of shikimic acid and some of its bacterial and mammalian metabolites. , 1983, Toxicology letters.
[47] B. Stavric,et al. Shikimic acid. , 1976, Food and Cosmetics Toxicology.
[48] I. Evans,et al. Carcinogenicity of bracken and shikimic acid , 1974, Nature.